Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · IEX Real-Time Price · USD
0.570
-0.014 (-2.33%)
At close: Jul 2, 2024, 4:00 PM
0.575
+0.005 (0.95%)
After-hours: Jul 2, 2024, 6:50 PM EDT
Kezar Life Sciences Market Cap
Kezar Life Sciences has a market cap or net worth of $41.50 million as of July 2, 2024. Its market cap has decreased by -75.92% in one year.
Market Cap
41.50M
Enterprise Value
-120.02M
1-Year Change
-75.92%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since June 21, 2018, Kezar Life Sciences's market cap has decreased from $319.30M to $41.50M, a decrease of -87.00%. That is a compound annual growth rate of -28.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 42.50M | -38.23% |
| Dec 29, 2023 | 68.80M | -85.71% |
| Dec 30, 2022 | 481.40M | -41.41% |
| Dec 31, 2021 | 821.70M | 240.25% |
| Dec 31, 2020 | 241.50M | 214.45% |
| Dec 31, 2019 | 76.80M | -82.97% |
| Dec 31, 2018 | 451.00M | 41.25% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioXcel Therapeutics | 42.03M |
| NextCure | 41.96M |
| Inotiv | 41.81M |
| Protara Therapeutics | 41.80M |
| Regencell Bioscience Holdings | 41.77M |
| Lucid Diagnostics | 40.89M |
| AEON Biopharma | 40.69M |
| Moolec Science | 40.57M |